INIS
drugs
100%
rats
94%
cancer
64%
therapy
54%
nanostructures
40%
inflammation
37%
nanoparticles
34%
breasts
32%
lipids
31%
liver
31%
comparative evaluations
31%
delivery
30%
antioxidants
28%
coronaviruses
27%
enzymes
26%
interactions
25%
receptors
25%
fibrosis
25%
fats
23%
diseases
23%
design
22%
covid-19
22%
in vivo
21%
applications
20%
evaluation
20%
molecules
19%
diet
19%
proteins
18%
growth factors
18%
inhibition
18%
bones
18%
optimization
17%
brain
17%
carriers
17%
petroleum ether
17%
molecular dynamics method
17%
blood
17%
in vitro
16%
silica
16%
management
16%
glucuronic acid
15%
validation
15%
hybrids
15%
lung cells
15%
quercetin
15%
simulation
15%
ligands
15%
pharmaceuticals
14%
kinases
13%
biological availability
13%
Pharmacology, Toxicology and Pharmaceutical Science
Resveratrol
63%
Rat
47%
Breast Cancer
32%
Fat
23%
Fenugreek
23%
Lipid
21%
Inflammation
21%
Pharmacokinetics
18%
Glucuronic Acid
15%
Mesoporous Silica Nanoparticle
15%
Receptor Antagonist
15%
Drug
15%
Bioavailability
12%
Wistar Rat
12%
Antagonist
11%
Petroleum Ether
11%
Receptor
11%
Malignant Neoplasm
11%
Protein
10%
Fibrosing Alveolitis
9%
Quercetin
9%
Rat Model
9%
Anti-Human Immunodeficiency Virus
9%
Ligand
9%
Postmenopause Osteoporosis
9%
Wound
9%
Drug Resistance
8%
Chitosan
8%
Nintedanib
8%
Nanomaterial
7%
Estrogen Receptor
7%
Hydrogen Potassium Adenosine Triphosphatase
7%
Swallow (Bird)
7%
Thalidomide
7%
Fusion Inhibitor
7%
Diethylnitrosamine
7%
Fluorouracil
7%
Zingiber Zerumbet
7%
Antibacterial Activity
7%
Flavone
7%
Moringa oleifera
7%
Ritonavir
7%
Drug Distribution
7%
Epidermal Growth Factor Receptor
7%
Transdermal Patch
7%
Non Small Cell Lung Cancer
7%
Annona muricata
7%
Neurotoxicity
7%
Amyloid
7%
Intranasal Route
7%
Medicine and Dentistry
Breast Cancer
16%
Obstetric Delivery
15%
Serositis
13%
Lipid
12%
Petroleum Ether
12%
Liver
12%
Nanoparticle
11%
Lipid Diet
11%
Development
10%
Therapeutic Procedure
10%
Cancer Therapy
9%
Biological Product
8%
Peroxisome Proliferator Activated Receptor
8%
Cancer Cell Line
7%
RNA Directed RNA Polymerase
7%
Adenosine Triphosphatase
7%
Wound Management
7%
Venous Ulcer
7%
Peptide
7%
Neurotoxicity
7%
PC12 Cell Line
7%
Agonist
7%
Chalcone Derivative
7%
Resveratrol
7%
Amyloid
7%
Receptor
7%
Flavone
7%
Biological Activity
7%
Chronic Inflammation
7%
Phenylhydrazine
7%
Carbene
7%
Indole Derivative
7%
Nanomaterial
7%
Antibacterial Activity
7%
Combination Therapy
7%
Idiopathic Pulmonary Fibrosis
7%
Wound Dressings
7%
Fructose
7%
3 Hydroxyflavone
7%
Lymph Duct
7%
Evaluation Study
7%
Fat
7%
Antidiabetic Activity
7%
Bone Marrow Suppression
7%
Annona muricata
7%
Cyclophosphamide
7%
Thalidomide
7%
Hypolipidemic Agent
7%
Glycogen Synthase Kinase 3 Inhibitor
7%
Streptozocin
7%